T39 — ICD-10-CM Diagnosis Codes

• T39 Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
• T39.0 Poisoning by, adverse effect of and underdosing of salicylates
• T39.01 Poisoning by, adverse effect of and underdosing of aspirin
• T39.011 Poisoning by aspirin, accidental (unintentional)
• T39.011A Poisoning by aspirin, accidental (unintentional), initial encounter billable
• T39.011D Poisoning by aspirin, accidental (unintentional), subsequent encounter billable
• T39.011S Poisoning by aspirin, accidental (unintentional), sequela billable
• T39.012 Poisoning by aspirin, intentional self-harm
• T39.012A Poisoning by aspirin, intentional self-harm, initial encounter billable
• T39.012D Poisoning by aspirin, intentional self-harm, subsequent encounter billable
• T39.012S Poisoning by aspirin, intentional self-harm, sequela billable
• T39.013 Poisoning by aspirin, assault
• T39.013A Poisoning by aspirin, assault, initial encounter billable
• T39.013D Poisoning by aspirin, assault, subsequent encounter billable
• T39.013S Poisoning by aspirin, assault, sequela billable
• T39.014 Poisoning by aspirin, undetermined
• T39.014A Poisoning by aspirin, undetermined, initial encounter billable
• T39.014D Poisoning by aspirin, undetermined, subsequent encounter billable
• T39.014S Poisoning by aspirin, undetermined, sequela billable
• T39.015 Adverse effect of aspirin
• T39.015A Adverse effect of aspirin, initial encounter billable
• T39.015D Adverse effect of aspirin, subsequent encounter billable
• T39.015S Adverse effect of aspirin, sequela billable
• T39.016 Underdosing of aspirin
• T39.016A Underdosing of aspirin, initial encounter billable
• T39.016D Underdosing of aspirin, subsequent encounter billable
• T39.016S Underdosing of aspirin, sequela billable
• T39.09 Poisoning by, adverse effect of and underdosing of other salicylates
• T39.091 Poisoning by salicylates, accidental (unintentional)
• T39.091A Poisoning by salicylates, accidental (unintentional), initial encounter billable
• T39.091D Poisoning by salicylates, accidental (unintentional), subsequent encounter billable
• T39.091S Poisoning by salicylates, accidental (unintentional), sequela billable
• T39.092 Poisoning by salicylates, intentional self-harm
• T39.092A Poisoning by salicylates, intentional self-harm, initial encounter billable
• T39.092D Poisoning by salicylates, intentional self-harm, subsequent encounter billable
• T39.092S Poisoning by salicylates, intentional self-harm, sequela billable
• T39.093 Poisoning by salicylates, assault
• T39.093A Poisoning by salicylates, assault, initial encounter billable
• T39.093D Poisoning by salicylates, assault, subsequent encounter billable
• T39.093S Poisoning by salicylates, assault, sequela billable
• T39.094 Poisoning by salicylates, undetermined
• T39.094A Poisoning by salicylates, undetermined, initial encounter billable
• T39.094D Poisoning by salicylates, undetermined, subsequent encounter billable
• T39.094S Poisoning by salicylates, undetermined, sequela billable
• T39.095 Adverse effect of salicylates
• T39.095A Adverse effect of salicylates, initial encounter billable
• T39.095D Adverse effect of salicylates, subsequent encounter billable
• T39.095S Adverse effect of salicylates, sequela billable
• T39.096 Underdosing of salicylates
• T39.096A Underdosing of salicylates, initial encounter billable
• T39.096D Underdosing of salicylates, subsequent encounter billable
• T39.096S Underdosing of salicylates, sequela billable
• T39.1 Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives
• T39.1X Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives
• T39.1X1 Poisoning by 4-Aminophenol derivatives, accidental (unintentional)
• T39.1X1A Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter billable
• T39.1X1D Poisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter billable
• T39.1X1S Poisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela billable
• T39.1X2 Poisoning by 4-Aminophenol derivatives, intentional self-harm
• T39.1X2A Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter billable
• T39.1X2D Poisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter billable
• T39.1X2S Poisoning by 4-Aminophenol derivatives, intentional self-harm, sequela billable
• T39.1X3 Poisoning by 4-Aminophenol derivatives, assault
• T39.1X3A Poisoning by 4-Aminophenol derivatives, assault, initial encounter billable
• T39.1X3D Poisoning by 4-Aminophenol derivatives, assault, subsequent encounter billable
• T39.1X3S Poisoning by 4-Aminophenol derivatives, assault, sequela billable
• T39.1X4 Poisoning by 4-Aminophenol derivatives, undetermined
• T39.1X4A Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter billable
• T39.1X4D Poisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter billable
• T39.1X4S Poisoning by 4-Aminophenol derivatives, undetermined, sequela billable
• T39.1X5 Adverse effect of 4-Aminophenol derivatives
• T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter billable
• T39.1X5D Adverse effect of 4-Aminophenol derivatives, subsequent encounter billable
• T39.1X5S Adverse effect of 4-Aminophenol derivatives, sequela billable
• T39.1X6 Underdosing of 4-Aminophenol derivatives
• T39.1X6A Underdosing of 4-Aminophenol derivatives, initial encounter billable
• T39.1X6D Underdosing of 4-Aminophenol derivatives, subsequent encounter billable
• T39.1X6S Underdosing of 4-Aminophenol derivatives, sequela billable
• T39.2 Poisoning by, adverse effect of and underdosing of pyrazolone derivatives
• T39.2X Poisoning by, adverse effect of and underdosing of pyrazolone derivatives
• T39.2X1 Poisoning by pyrazolone derivatives, accidental (unintentional)
• T39.2X1A Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter billable
• T39.2X1D Poisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter billable
• T39.2X1S Poisoning by pyrazolone derivatives, accidental (unintentional), sequela billable
• T39.2X2 Poisoning by pyrazolone derivatives, intentional self-harm
• T39.2X2A Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter billable
• T39.2X2D Poisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter billable
• T39.2X2S Poisoning by pyrazolone derivatives, intentional self-harm, sequela billable
• T39.2X3 Poisoning by pyrazolone derivatives, assault
• T39.2X3A Poisoning by pyrazolone derivatives, assault, initial encounter billable
• T39.2X3D Poisoning by pyrazolone derivatives, assault, subsequent encounter billable
• T39.2X3S Poisoning by pyrazolone derivatives, assault, sequela billable
• T39.2X4 Poisoning by pyrazolone derivatives, undetermined
• T39.2X4A Poisoning by pyrazolone derivatives, undetermined, initial encounter billable
• T39.2X4D Poisoning by pyrazolone derivatives, undetermined, subsequent encounter billable
• T39.2X4S Poisoning by pyrazolone derivatives, undetermined, sequela billable
• T39.2X5 Adverse effect of pyrazolone derivatives
• T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter billable
• T39.2X5D Adverse effect of pyrazolone derivatives, subsequent encounter billable
• T39.2X5S Adverse effect of pyrazolone derivatives, sequela billable
• T39.2X6 Underdosing of pyrazolone derivatives
• T39.2X6A Underdosing of pyrazolone derivatives, initial encounter billable
• T39.2X6D Underdosing of pyrazolone derivatives, subsequent encounter billable
• T39.2X6S Underdosing of pyrazolone derivatives, sequela billable
• T39.3 Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID]
• T39.31 Poisoning by, adverse effect of and underdosing of propionic acid derivatives
• T39.311 Poisoning by propionic acid derivatives, accidental (unintentional)
• T39.311A Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter billable
• T39.311D Poisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter billable
• T39.311S Poisoning by propionic acid derivatives, accidental (unintentional), sequela billable
• T39.312 Poisoning by propionic acid derivatives, intentional self-harm
• T39.312A Poisoning by propionic acid derivatives, intentional self-harm, initial encounter billable
• T39.312D Poisoning by propionic acid derivatives, intentional self-harm, subsequent encounter billable
• T39.312S Poisoning by propionic acid derivatives, intentional self-harm, sequela billable
• T39.313 Poisoning by propionic acid derivatives, assault
• T39.313A Poisoning by propionic acid derivatives, assault, initial encounter billable
• T39.313D Poisoning by propionic acid derivatives, assault, subsequent encounter billable
• T39.313S Poisoning by propionic acid derivatives, assault, sequela billable
• T39.314 Poisoning by propionic acid derivatives, undetermined
• T39.314A Poisoning by propionic acid derivatives, undetermined, initial encounter billable
• T39.314D Poisoning by propionic acid derivatives, undetermined, subsequent encounter billable
• T39.314S Poisoning by propionic acid derivatives, undetermined, sequela billable
• T39.315 Adverse effect of propionic acid derivatives
• T39.315A Adverse effect of propionic acid derivatives, initial encounter billable
• T39.315D Adverse effect of propionic acid derivatives, subsequent encounter billable
• T39.315S Adverse effect of propionic acid derivatives, sequela billable
• T39.316 Underdosing of propionic acid derivatives
• T39.316A Underdosing of propionic acid derivatives, initial encounter billable
• T39.316D Underdosing of propionic acid derivatives, subsequent encounter billable
• T39.316S Underdosing of propionic acid derivatives, sequela billable
• T39.39 Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID]
• T39.391 Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional)
• T39.391A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter billable
• T39.391D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter billable
• T39.391S Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), sequela billable
• T39.392 Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm
• T39.392A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter billable
• T39.392D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter billable
• T39.392S Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, sequela billable
• T39.393 Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault
• T39.393A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter billable
• T39.393D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter billable
• T39.393S Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, sequela billable
• T39.394 Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined
• T39.394A Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter billable
• T39.394D Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter billable
• T39.394S Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, sequela billable
• T39.395 Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID]
• T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter billable
• T39.395D Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter billable
• T39.395S Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela billable
• T39.396 Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID]
• T39.396A Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter billable
• T39.396D Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter billable
• T39.396S Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela billable
• T39.4 Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified
• T39.4X Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified
• T39.4X1 Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional)
• T39.4X1A Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter billable
• T39.4X1D Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter billable
• T39.4X1S Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), sequela billable
• T39.4X2 Poisoning by antirheumatics, not elsewhere classified, intentional self-harm
• T39.4X2A Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter billable
• T39.4X2D Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter billable
• T39.4X2S Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela billable
• T39.4X3 Poisoning by antirheumatics, not elsewhere classified, assault
• T39.4X3A Poisoning by antirheumatics, not elsewhere classified, assault, initial encounter billable
• T39.4X3D Poisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter billable
• T39.4X3S Poisoning by antirheumatics, not elsewhere classified, assault, sequela billable
• T39.4X4 Poisoning by antirheumatics, not elsewhere classified, undetermined
• T39.4X4A Poisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter billable
• T39.4X4D Poisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter billable
• T39.4X4S Poisoning by antirheumatics, not elsewhere classified, undetermined, sequela billable
• T39.4X5 Adverse effect of antirheumatics, not elsewhere classified
• T39.4X5A Adverse effect of antirheumatics, not elsewhere classified, initial encounter billable
• T39.4X5D Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter billable
• T39.4X5S Adverse effect of antirheumatics, not elsewhere classified, sequela billable
• T39.4X6 Underdosing of antirheumatics, not elsewhere classified
• T39.4X6A Underdosing of antirheumatics, not elsewhere classified, initial encounter billable
• T39.4X6D Underdosing of antirheumatics, not elsewhere classified, subsequent encounter billable
• T39.4X6S Underdosing of antirheumatics, not elsewhere classified, sequela billable
• T39.8 Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified
• T39.8X Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified
• T39.8X1 Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional)
• T39.8X1A Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter billable
• T39.8X1D Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), subsequent encounter billable
• T39.8X1S Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), sequela billable
• T39.8X2 Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm
• T39.8X2A Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter billable
• T39.8X2D Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, subsequent encounter billable
• T39.8X2S Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, sequela billable
• T39.8X3 Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault
• T39.8X3A Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter billable
• T39.8X3D Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter billable
• T39.8X3S Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, sequela billable
• T39.8X4 Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined
• T39.8X4A Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter billable
• T39.8X4D Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, subsequent encounter billable
• T39.8X4S Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, sequela billable
• T39.8X5 Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified
• T39.8X5A Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter billable
• T39.8X5D Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter billable
• T39.8X5S Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela billable
• T39.8X6 Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified
• T39.8X6A Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter billable
• T39.8X6D Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter billable
• T39.8X6S Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela billable
• T39.9 Poisoning by, adverse effect of and underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic
• T39.91 Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional)
• T39.91XA Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter billable
• T39.91XD Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter billable
• T39.91XS Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), sequela billable
• T39.92 Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm
• T39.92XA Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter billable
• T39.92XD Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter billable
• T39.92XS Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela billable
• T39.93 Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault
• T39.93XA Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter billable
• T39.93XD Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter billable
• T39.93XS Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, sequela billable
• T39.94 Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined
• T39.94XA Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter billable
• T39.94XD Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter billable
• T39.94XS Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, sequela billable
• T39.95 Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic
• T39.95XA Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter billable
• T39.95XD Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter billable
• T39.95XS Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela billable
• T39.96 Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic
• T39.96XA Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter billable
• T39.96XD Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter billable
• T39.96XS Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela billable